Thursday, 17 November 2016

First-generation Cephalosporins show Promise in Tuberculosis Therapy


Tuberculosis (TB) is the most deadly infectious disease in the world with treatment spanning for up to 6 months; however, in case of MDR-TB, it can even go up to 2 years. Research shows that the cost of developing a new drug is quite huge. Now, one research published in Scientific Reports shows that first generation cephalosporins could be a potential treatment for TB.  Read more 



Posted by Dr. Tim Sandle